TPD52L2 antibody (C-Term)
Quick Overview for TPD52L2 antibody (C-Term) (ABIN334516)
Target
See all TPD52L2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- C-Term
-
Purpose
- TPD52L2 / D54
-
Sequence
- SGDKPLSDPA P
-
Specificity
- This antibody is expected to recognise all reported isoforms (NP_955392.1, NP_955393.1, NP_955394.1, NP_955395.1, NP_003279.2, NP_955391.1).
-
Cross-Reactivity
- Human
-
Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence C-SGDKPLSDPAP, from the C Terminus of the protein sequence according to NP_955392.1, NP_955393.1, NP_955394.1, NP_955395.1, NP_003279.2, NP_955391.1.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Immunohistochemistry: Paraffin embedded Human Spleen, Tonsil and Brain (Cortex). Recommended concentration: 3.75 μg/mL.
Western Blot: Approx 28 kDa band observed in Human Breast Cancer and Human Brain lysates (calculated MW of 24.9 kDa according to NP_955392.1). Recommended concentration: 0.1-0.3 μg/mL. Primary incubation was 1 hour. See also our D52 and D53 products.
Peptide ELISA: antibody detection limit dilution 1:16000.
-
Comment
-
Additional validation: This antibody has been successfully used in the following paper: Sikorski et al. (2018) PMID: 30377371.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
-